Company attributes
Location
B2X
AngelList URL
Pitchbook URL
Legal Name
Ritter Pharmaceuticals, Inc.
Legal classification
Number of Employees (Ranges)
11 – 50
Founded Date
2004
Total Funding Amount (USD)
33,190,414
Latest Funding Round Date
December 2015
Latest Funding Type
Patents Assigned (Count)
11
Wellfound ID
Other attributes
Company Operating Status
Closed
Latest Funding Round Amount (USD)
10,000,000
Ritter Pharmaceuticals is a company that creates novel therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases. Its lead product, RP-G28, has potential to become FDA-approved treatment for lactose intolerance.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
